Podcast of the Royal Belgian Society of Dermatology and Venereology.
Royal Belgian Society of Dermatology and Venereology's podcast
Claim This Podcastby Royal Belgian Society of Dermatology and Venereology
5.0(2 reviews)
21 episodes
Updated Weekly
Accepts GuestsHas SponsorsLocation 🇧🇪
24
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality25
Social0
YouTube0
Engagement60
Podcast Overview
Podcast of the Royal Belgian Society of Dermatology and Venereology.
Language
🇺🇲
Publishing Since
7/6/2021
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
24
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality25
Social0
YouTube0
Engagement60
6
Excellent Areas
2
Good Performance
11
Growth Opportunities
excellent
Episode Length
21 minutes
Performing excellently!
good
Show Notes Quality
3.0/5
Recommendations available
Unlock the full report to see detailed tips
poor
Publishing Consistency
Every 100 days
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
2 verified contact emails on file for Royal Belgian Society of Dermatology and Venereology's podcast
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
June 9, 2026
Summer holiday skin problems with dr. Niels Horst (NL)
<p class= "font-claude-response-body break-words whitespace-normal leading-[1.7]"> <img src= "//assets.libsyn.com/show/355205/fab861c7-1450-4edf-b1b2-4af5633b58a1.png" alt="" width="500" height="281" /></p> <p class= "font-claude-response-body break-words whitespace-normal leading-[1.7]"> </p> <p class= "font-claude-response-body break-words whitespace-normal leading-[1.7]"> In this episode, <strong>Dr. Niels Horst</strong> offers a systematic review of the dermatological conditions most frequently encountered in returning travellers. Drawing on clinical experience, he examines the diagnostic clues, differential considerations and management principles that underpin sound decision-making in travel dermatology.</p> <p class= "font-claude-response-body break-words whitespace-normal leading-[1.7]"> The discussion is structured around five domains. The first addresses <strong>photo-induced dermatoses</strong>, including sunburn, polymorphic light eruption, and the clinical distinction between phototoxic and photoallergic reactions, alongside miliaria. The second considers <strong>aquatic exposures</strong>, covering seabather's eruption, swimmer's itch, hot tub folliculitis and the management of coral injuries with their attendant risk of marine infection, including Vibrio species. The third focuses on <strong>arthropod-related conditions</strong>, with particular attention to cutaneous larva migrans, tungiasis, bedbug bites, and the threshold for empirical treatment of erythema migrans. The fourth examines <strong>tropical and infectious presentations</strong>, including pityriasis versicolor, impetigo and secondary bacterial infection, myiasis, and the cutaneous manifestations of arboviral disease such as dengue and Zika. The final section addresses <strong>contact and allergic reactions</strong>, encompassing jellyfish envenomation, phytodermatoses, photocontact allergy to cosmetics and sunscreens, and the clinically significant sensitisation associated with paraphenylenediamine in black henna tattoos.</p> <p class= "font-claude-response-body break-words whitespace-normal leading-[1.7]"> Each topic is approached with an emphasis on history-taking, recognition of pathognomonic features, and the avoidance of common diagnostic and therapeutic pitfalls. The episode concludes with <strong>three guiding principles</strong> for the assessment of any patient presenting with a dermatosis following international travel.</p> <p class= "font-claude-response-body break-words whitespace-normal leading-[1.7]"> Essential listening for dermatologists seeking to refine their approach to travel-associated skin disease.</p>
May 15, 2026
GLP-Agonists in dermatology (Glucagon-Like Peptide 1) with Samira Baharlou.
<p class= "font-claude-response-body break-words whitespace-normal leading-[1.7]"> <img src="//assets.libsyn.com/show/355205/samira_glp1.png" alt="" width="500" height="285" /></p> <p class= "font-claude-response-body break-words whitespace-normal leading-[1.7]"> In this episode, we explore one of the most intriguing crossroads in modern medicine: the unexpected territory where metabolic therapy meets the skin.</p> <p class= "font-claude-response-body break-words whitespace-normal leading-[1.7]"> GLP-1 receptor agonists have transformed the treatment of type 2 diabetes and obesity — but dermatologists are now noticing that these medications may be doing far more than regulating blood sugar and body weight. From inflammatory skin diseases to wound healing, from aesthetic procedures to obesity-related skin conditions, the implications for dermatology are only beginning to unfold.</p> <p class= "font-claude-response-body break-words whitespace-normal leading-[1.7]"> To make sense of it all, I'm joined by dermatologist Dr. Samira Baharlou. Together, we discuss:</p> <ul class= "[li_&]:mb-0 [li_&]:mt-1 [li_&]:gap-1 [&:not(:last-child)_ul]:pb-1 [&:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3"> <li class="whitespace-normal break-words pl-2">What the current evidence says about GLP agonists beyond diabetes and obesity, and how the incretin pathway influences inflammation and immunity</li> <li class="whitespace-normal break-words pl-2">Their potential role in psoriasis, hidradenitis suppurativa, and atopic dermatitis</li> <li class="whitespace-normal break-words pl-2">The skin-related side effects Belgian dermatologists are already encountering in daily practice</li> <li class="whitespace-normal break-words pl-2">What we know about wound healing, tissue regeneration, and the risks before and after dermatologic surgery</li> <li class="whitespace-normal break-words pl-2">How to approach patients on GLP agonists who want laser treatments, fillers, or aesthetic procedures</li> <li class="whitespace-normal break-words pl-2">Which dermatology patients may benefit most — including those with acanthosis nigricans, lymphedema, or post-bariatric skin issues</li> <li class="whitespace-normal break-words pl-2">And finally, where the field is heading, with dual and triple agonists already in the research pipeline</li> </ul> <p class= "font-claude-response-body break-words whitespace-normal leading-[1.7]"> A grounded, thoughtful conversation about a rapidly evolving topic — relevant for clinicians, researchers, and anyone curious about how a class of metabolic drugs is starting to reshape dermatology.</p> <p class= "font-claude-response-body break-words whitespace-normal leading-[1.7]"> Enjoy the episode.</p>
December 15, 2025
Dermatosurgery (by Prof dr. Lieve Brochez)
<p><img src= "https://static.wixstatic.com/media/77e6af_4941acc80c8146f087c2d044f0dcc5e4~mv2.png" alt="" width="600" height="338" /></p>
21 total episodes available
Similar Podcasts
Discover related shows you might enjoy
Deep-dive analytics for Royal Belgian Society of Dermatology and Venereology's podcast
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Royal Belgian Society of Dermatology and Venereology's podcast?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 7 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.